A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas

Figure 4

Nomogram establishment and assessment. (a) Nomogram for predicting OS in patients with LGGs. (b) Time-dependent ROC curve. (c) Decision curve analysis to assess 3-year IRSS, IDH status, and nomogram net benefit. (d) The calibration curve for predicting OS rate at 1, 3, and 5 years.

(a)

(b)

(c)

(d)